| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovaBay Pharmaceuticals, Inc. | Director | Restricted Stock Units | 30,000 | $54,300 | $1.81 | 28 May 2024 | Direct |
| Mars Acquisition Corp. | Director | Ordinary Share | 51,750 | 13 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals, Inc. | 28 May 2024 | 1 | $0 | 4 | Director | 30 May 2024, 21:22 |
| NBY | NovaBay Pharmaceuticals, Inc. | 09 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 17:03 |
| NBY | NovaBay Pharmaceuticals, Inc. | 11 May 2023 | 2 | $0 | 4 | Director | 15 May 2023, 18:54 |
| /report/000110465923020210-zheng-yenyou-2023-02-13 | Mars Acquisition Corp. | 13 Feb 2023 | 0 | $0 | 3 | Director | 13 Feb 2023, 20:48 |
| NBY | NovaBay Pharmaceuticals, Inc. | 21 May 2022 | 2 | $0 | 4 | Director | 24 May 2022, 19:31 |
| NBY | NovaBay Pharmaceuticals, Inc. | 11 May 2022 | 1 | $0 | 4 | Director | 13 May 2022, 20:32 |
| NBY | NovaBay Pharmaceuticals, Inc. | 21 May 2021 | 1 | $0 | 4 | Director | 25 May 2021, 16:46 |